Differential potentiative effects of glutamate receptor antagonists in the production of antinociception induced by opioids administered intrathecally in the mouse

Brain Research Bulletin

Volumn 52, Issue 2, 2000, Pages 143-150

  Suh, Hong Won ^a   Song, Dong Keun ^a   Huh, Sung Oh ^a   Kim, Yung Hi ^a  

^a Hallym University   (South Korea)

Author keywords

Endorphin; 488H; Antinociception; DAMGO; DPDPE; Glutamate receptors; Morphine; Spinal cord; U50

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; BETA ENDORPHIN; DELTA OPIATE RECEPTOR; DIZOCILPINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; KAPPA OPIATE RECEPTOR; METHYSERGIDE; MORPHINE; NALOXONE; OPIATE AGONIST; OPIATE ANTAGONIST; OPIATE RECEPTOR; SIGMA OPIATE RECEPTOR; YOHIMBINE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG POTENTIATION; DRUG RECEPTOR BINDING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; TAIL FLICK TEST;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; 6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ANALGESICS, OPIOID; ANIMALS; BETA-ENDORPHIN; DIZOCILPINE MALEATE; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; EXCITATORY AMINO ACID ANTAGONISTS; INJECTIONS, SPINAL; MALE; MICE; MICE, INBRED ICR; PAIN; SPINAL CORD; TIME FACTORS;

EID: 0034658283     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(00)00250-1     Document Type: Article

References (50)

1. D'Amour F.E., Smith D.L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:1941;74-79.
2. Broadbear J.H., Negus S.S., Butelman E.R., de Costa B.R., Woods J.H. Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay. Psychopharmacology. 115:1994;311-319.
3. Budai D., Larson A.A. The involvement of metabotropic glutamate receptors in sensory transmission in dorsal horn of the rat spinal cord. Neuroscience. 83:1998;571-580.
4. Coderre T.J., Van Empel I. The utility of excitatory amino acid. (EAA) antagonists as analgesic agents. I. Comparison of the antinociceptive activity of various classes of EAA antagonists in mechanical, thermal and chemical nociceptive tests. Pain. 59:1994;345-352.
5. Eisenach, J. C.; Gebhart, G. F. Intrathecal amitriptyline. Antinociceptive interactions with intravenous morphine and intrathecal clonidine, neostigmine, and carbamylcholine in rats. Anesthesiology 83:1036-1045; 1995.
6. Endoh T., Matsnura H., Tanaka C., Nagase H. Nor-binaltorphimine A potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo . Arch. Int. Pharmacodyn. Ther. 316:1992;30-42.
7. Ferreira S.H., Lorenzetti B.B. Glutamate spinal retrograde sensitization of primary sensory neurons associated with nociception. Neuropharmacology. 33:1994;1479-1485.
8. Furst S. Transmitters involved in antinociception in the spinal cord. Brain Res. Bull. 48:1999;129-141.
9. He L., Lee N.M. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord. J. Pharmacol. Exp. Ther. 285:1998;1181-1186.
10. Heyman J.S., Mulvaney S.A., Mosberg H.I., Porreca F. Opioid δ-receptor involvement in supraspinal and spinal antinociception in mice. Brain Res. 420:1987;100-108.
11. Horvath H., Benedek G., Szikszay M. Enhancement of fentanyl analgesia by clonidine plus verapamil in rats. Anesth. Analg. 70:1990;284-288.
12. Hylden J.L.K., Wilcox G.L. Intrathecal morphine in mice A new technique . Eur. J. Pharmacol. 67:1980;313-316.
13. Grass, S.; Hoffmann, O.; Xu, X. J.; Wiesenfeld-Hallin, Z. N-methyl-D-aspartate receptor antagonists potentiate morphine's antinociceptive effect in the rat. Acta Physiol. Scand. 158:269-273; 1996.
14. Kunihara M., Ohyama M., Nakano M. Central monoaminergic mechanisms in mice and analgesic activity of spiradoline mesylate, a selective kappa-opioid receptor agonist. Eur. J. Pharmacol. 214:1992;111-118.
15. Lu S.M., Yeh H.H. Ethanol modulates AMPA-induced current responses of primary somatosensory cortical neurons. Neurochem. Int. 35:1999;175-183.
16. Lutfy K., Shen K.Z., Woodward R.M., Weber E. Inhibition of morphine tolerance by NMDA receptor antagonists in the formalin test. Brain Res. 731:1996;171-181.
17. Lutfy K., Shen K.Z., Woodward R.M., Weber E. Antinociceptive effects of NMDA and non-NMDA receptor antagonists in the tail flick test in mice. Pain. 70:1997;31-40.
18. B antagonists attenuate the antinociception produced by microinjection of L-glutamate into the ventromedial medulla of the rat. Brain Res. 607:1993;39-46.
19. A receptors . Brain Res. 620:1993;86-96.
20. Malmberg A.B., Yaksh T.L. Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science. 257:1992;1276-1279.
21. Martin, L. J.; Al-Abdulla, N. A.; Brambrink, A. M.; Kirsch, J. R.; Sieber, F. E.; Portera-Cailliau, C. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosis. Brain Res. Bull. 46:281-309; 1998.
22. Mattia A., Farmer S.C., Takemori A.E., Sultana M., Portoghese P.S., Mosberg H.I., Bowen W.D., Porreca F. Spinal opioid delta antinociception in the mouse Mediation by a 5′-NTII-sensitive delta receptor subtype . J. Pharmacol. Exp. Ther. 260:1992;518-525.
23. Meller S.T., Dykstra C.L., Gebhart G.F. Acute mechanical hyperalgesia is produced by coactivation of AMPA and metabotropic glutamate receptors. NeuroReport. 4:1993;879-882.
24. Millan M.J., Seguin L. Chemically-diverse ligands at the glycine B site coupled to N-methyl-D-aspartate (NMDA) receptors selectively block the late phase of formalin-induced pain in mice. Neurosci. Lett. 178:1994;139-143.
25. Mishra, O. P.; Delivoria-Papadopoulos, M. Cellular mechanisms of hypoxic injury in the developing brain. Brain Res. Bull. 48:233-238; 1999.
26. Murray C.W., Cowan A., Larson A.A. Neurokinin and NMDA antagonists (but not a kainic acid antagonist) are antinociceptive in the mouse formalin model. Pain. 44:1991;179-185.
27. Ossipov M.H., Suarez L.J., Spaulding T.C. Antinociceptive interactions between alpha 2-adrenergic and opiate agonists at the spinal level in rodents. Anesth. Analg. 68:1989;194-200.
28. Paul D., Hornby P.J. Potentiation of intrathecal DAMGO antinociception, but not gastrointestinal transit inhibition, by 5-hydroxytryptamine and norepinephrine uptake blockade. Life Sci. 56:1995;L83-L87.
29. Pelissier T., Paeile C., Soto-Moyano R., Saavedra H., Hernandez A. Analgesia produced by intrathecal administration of the k opioid agonist, U50, 488H, on formalin-evoked cutaneous pain in the rat. Eur. J. Pharmacol. 190:1990;287-293.
30. Ren K., Williams G.M., Hylden J.L., Ruda M.A., Dubner R. The intrathecal administration of excitatory amino acid receptor antagonists selectively attenuated carrageenan-induced behavioral hyperalgesia in rats. Eur. J. Pharmacol. 219:1992;235-243.
31. Sakurada T., Wako K., Sugiyama A., Sakurada C., Tan-No K., Kisara K. Involvement of spinal NMDA receptors in capsaicin-induced nociception. Pharmacol. Biochem. Behav. 59:1998;339-345.
32. Silva E., Cleland C.L., Gebhart G.F. Contributions of glutamate receptors to the maintenance of mustard oil-induced hyperalgesia in spinalized rats. Exp. Brain Res. 117:1997;379-388.
33. Sluka K.A., Jordan H.H., Willis W.D., Westlund K.N. Differential effects of N-methyl-D-aspartate (NMDA) and non-NMDA receptor antagonists on spinal release of amino acids after development of acute arthritis in rats. Brain Res. 664:1994;77-84.
34. Srivastava R.K., Gombar K.K., Kaur A.H., Khosla P. Attenuation of morphine-induced antinociception by L-glutamic acid at the spinal site in rats. Can. J. Anaesth. 42:1995;541-546.
35. Suh H.H., Tseng L.F. Intrathecal β-funaltrexamine antagonizes intracerebroventricular β-endorphin- but not morphine-induced analgesia in mice. J. Pharmacol. Exp. Ther. 245:1990;587-593.
36. Suh H.H., Tseng L.F. Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and β-endorphin in mice. Naunyn Schmiedebergs Arch. Pharmacol. 342:1990;67-71.
37. Suh H.H., Tseng L.F. Lack of antinociceptive cross-tolerance between intracerebroventricularly administered β-endorphin and morphine or DPDPE in mice. Life Sci. 46:1990;759-765.
38. Suh H.H., Tseng L.F. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by β-endorphin given intracerebroventricularly in mice. J. Pharmacol. Exp. Ther. 253:1990;981-986.
39. 5-enkephalin- and U50, 488H-induced analgesia in mice. Neuropharmacology. 27:1988;957-963.
40. Suh H.W., Fujimoto J.M., Tseng L.F. Differential mechanisms mediating β-endorphin- and morphine-induced analgesia in mice. Eur. J. Pharmacol. 168:1989;61-70.
41. Suh H.W., Song D.K., Kim Y.H., Yoo J.S., Tseng L.F. Differential antagonism by MK-801 against antinociception induced by opioid receptor agonists administered supraspinally in mice. Eur. J. Pharmacol. 263:1994;217-221.
42. 5-enkephalin and U50, 488H administered intracerebroventricularly in mice. Neuropeptides. 28:1995;125-129.
43. Tive L.A., Barr G.A. Analgesia from the periaqueductal gray in the developing rat Focal injections of morphine or glutamate and effects of intrathecal injection of methysergide or phentolamine . Brain Res. 584:1992;92-109.
44. Tseng L.F., Collins K.A. The tail-flick inhibition induced by beta-endorphin administered intrathecally is mediated by activation of kappa- and mu-opioid receptors in the mouse. Eur. J. Pharmacol. 214:1992;59-65.
45. Tseng L.F., Henneberry B., Collins B.K.A. The antinociception induced by beta-endorphin administered intrathecally is mediated by the activation of mu-. and kappa-opioid receptors in the rat. Naunyn-Schmiedebergs Arch. Pharmacol. 351:1995;464-468.
46. Ushijima I., Horita A. Cocaine Evidence for NMDA- and opioid-mediated antinociception in the tail-flick test . Pharmacol. Biochem. Behav. 44:1993;365-370.
47. Wang X.M., Yuan B., Hou Z.L. Role of the deep mesencephalic nucleus in the antinociception induced by stimulation of the anterior pretectal nucleus in rats. Brain Res. 577:1992;321-325.
48. Wei Z.Y., Karim F., Roerig S.C. Spinal morphine/clonidine antinociceptive synergism Involvement of G proteins and N-type voltage-dependent calcium channels . J. Pharmacol. Exp. Ther. 278:1996;1392-1407.
49. Wei Z.Y., Roerig S.C. Spinal morphine/clonidine antinociceptive synergism is regulated by protein kinase C, but not protein kinase A activity. J. Pharmacol. Exp. Ther. 287:1998;937-943.
50. Wong C., Yarbrough G.G. Effects of the diethyl and dimethyl esters of glutamic acid on morphine anti-nociception in the rat. Can. J. Physiol. Pharmacol. 53:1975;509-512.